Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

March 17, 2025

Study Completion Date

March 17, 2025

Conditions

Open Angle Glaucoma

Interventions

DRUG

NCX 470

NCX 470 0.1% vs Placebo

DRUG

Placebo

NCX 0.1% vs Placebo

Trial Locations (1)

Mayo Clinic, Rochester

All Listed Sponsors

lead

Nicox Ophthalmics, Inc.

INDUSTRY

NCT05938699 - Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution | Biotech Hunter | Biotech Hunter